Galera Therapeutics, Inc. Common Stock

Go to Galera Therapeutics, Inc. Common Stock Website

$0.02

0.00 (3.33%)
Live
Previous Close

$0.0225

Day Range

$0.0229 - $0.024

Previous Day Range

$0.0225 - $0.023

Market Cap

$ USD

Day Vol.

34700

Previous Day Vol.

694

Currency

USD

Primary Exchange

Nasdaq

GALERA THERAPEUTICS INC...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Kailera Therapeutics, a clinical-stage biopharmaceutical company, has launched with a $400 million Series A financing to advance its portfolio of next-generation therapies for obesity and related conditions. The company's lead program, KAI-9531, an injectable GLP-1/GIP receptor dual agonist, demonstrated positive results in Phase 2 trials in China.

Related tickers: GRTX.

Read Full Article

Galera's First Quarter 2024 Earnings Release

Related tickers: GRTX.

Read Full Article
Trending Tickers

Please sign in to view